Cite
HARVARD Citation
Castenmiller, S. et al. (2022). Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments. Immuno-oncology technology. p. . [Online].